Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)

SHE:002082 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	56.86	158.73	226.61	467.62	912.02	574.18
Short-Term Investments	-	11.15	-	-	-	-
Cash & Short-Term Investments	56.86	169.88	226.61	467.62	912.02	574.18
Cash Growth	-70.42%	-25.04%	-51.54%	-48.73%	58.84%	-26.55%
Accounts Receivable	1,082	1,038	1,157	1,263	1,157	1,311
Other Receivables	34.15	18.57	58.67	57.15	20.54	41
Receivables	1,116	1,056	1,216	1,320	1,178	1,352
Inventory	212.27	213.86	255.91	283.15	261.41	850.89
Prepaid Expenses	-	5.58	3.31	4.46	4.13	-
Other Current Assets	364	357.81	221.63	125.34	113.66	305.29
Total Current Assets	1,750	1,803	1,923	2,201	2,469	3,082
Property, Plant & Equipment	1,547	1,564	1,495	1,274	1,175	1,739
Long-Term Investments	-	112.08	10.52	12.35	12.91	15.3
Goodwill	126.19	125.67	125.46	127.93	194.79	217.87
Other Intangible Assets	463.55	461.79	418.46	430.97	398.65	491.68
Long-Term Accounts Receivable	-	14.06	12.79	6.57	3.97	5.88
Long-Term Deferred Tax Assets	130.75	134.44	113.62	90.54	54.23	47.02
Long-Term Deferred Charges	57.75	63.04	58.5	30.2	23.52	19.89
Other Long-Term Assets	195.82	48.91	138.69	44.47	39.06	44
Total Assets	4,271	4,327	4,296	4,218	4,371	5,662
Accounts Payable	224.62	247.36	302.55	231.18	254.51	355.61
Accrued Expenses	17.38	67.33	73.08	63.79	95.99	132.8
Short-Term Debt	739.57	855.17	825.43	677.96	572.21	1,116
Current Portion of Long-Term Debt	55.88	54.19	54.27	37.28	31.5	12.11
Current Portion of Leases	-	3.24	2.65	0.55	0.54	-
Current Income Taxes Payable	39.89	18.13	17.34	24.6	190.25	49.29
Current Unearned Revenue	34.71	16.82	14.31	30.28	33.21	75.65
Other Current Liabilities	57.21	54.02	36.98	71.61	105.19	123.33
Total Current Liabilities	1,169	1,316	1,327	1,137	1,283	1,865
Long-Term Debt	181.21	104	81.51	135.2	237	746.8
Long-Term Leases	13.19	11.61	11.99	13.43	1.22	-
Long-Term Unearned Revenue	91	92.18	70.54	68.06	59.37	102.52
Long-Term Deferred Tax Liabilities	44.68	44.21	40.83	39.36	33.5	31.07
Other Long-Term Liabilities	2.14	2.68	5.91	6.48	12.19	58.75
Total Liabilities	1,501	1,571	1,537	1,400	1,627	2,804
Common Stock	616.69	616.69	616.69	618.22	618.22	618.22
Additional Paid-In Capital	311.78	311.78	311.78	305.79	305.79	320.08
Retained Earnings	1,842	1,827	1,820	1,844	1,751	1,708
Treasury Stock	-59.99	-59.99	-59.99	-59.99	-50.96	-
Comprehensive Income & Other	-27.04	-28.34	-30.92	-21	-25.88	-24.21
Total Common Equity	2,683	2,667	2,658	2,687	2,598	2,622
Minority Interest	86.28	89.64	101.28	131.02	146.33	236.47
Shareholders' Equity	2,770	2,756	2,759	2,818	2,745	2,858
Total Liabilities & Equity	4,271	4,327	4,296	4,218	4,371	5,662
Total Debt	989.84	1,028	975.84	864.42	842.48	1,875
Net Cash (Debt)	-932.98	-858.34	-749.23	-396.8	69.54	-1,301
Net Cash Per Share	-1.52	-1.39	-1.22	-0.64	0.11	-2.15
Filing Date Shares Outstanding	611.69	611.69	611.69	613.22	614.08	618.22
Total Common Shares Outstanding	611.69	611.69	611.69	613.22	614.08	618.22
Working Capital	580.37	487.05	596.66	1,064	1,185	1,217
Book Value Per Share	4.39	4.36	4.34	4.38	4.23	4.24
Tangible Book Value	2,094	2,079	2,114	2,128	2,005	1,912
Tangible Book Value Per Share	3.42	3.40	3.46	3.47	3.26	3.09
Buildings	-	893.08	700.33	577.02	530.22	381.11
Machinery	-	777.07	703.7	679.8	668.65	1,226
Construction In Progress	-	510.85	611.33	472.39	380.88	1,043

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.